SCHEMBL26328490

SCHEMBL26328490

COC(OCc1ccccc1)/C(=N/O)c1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.42
MEN1 O00255 2/20 0.42
RCE1 Q9Y256 1/20 0.42
SLC6A2 P23975 2/20 0.38
SLC6A3 Q01959 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MAPT P10636 3/20 0.37
HTT P42858 3/20 0.36
SLC1A3 P43003 2/20 0.36
SLC1A2 P43004 2/20 0.36
SLC1A1 P43005 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP2C19 P33261 1/20 0.36
ATM Q13315 1/20 0.36
ALDH1A1 P00352 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SLC6A4 P31645 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4864675 0.83 KMT2A (0.51) KMT2AMEN1MAPTHTTCYP2C19
SCHEMBL7720206 0.73 SLC1A3 (0.47) KMT2AMEN1RCE1SLC6A2SLC6A3
SCHEMBL11402422 0.72 ALDH1A1 (0.55) KMT2AMEN1SLC6A2SLC6A3TDP1
SCHEMBL9460924 0.72 MAPT (0.43) KMT2AMEN1RCE1SLC6A2SLC6A3
SCHEMBL8777036 0.71 KMT2A (0.50) KMT2AMEN1MAPTCYP2C19ALDH1A1
SCHEMBL9221950 0.70 MMP1 (0.47) KMT2AMEN1SLC1A3SLC1A2SLC1A1
SCHEMBL11806967 0.69 KMT2A (0.53) KMT2AMEN1SLC6A2SLC6A3TDP1
SCHEMBL28031207 0.69 PPARG (0.41) KMT2AMEN1RCE1SLC6A2SLC6A3
SCHEMBL3344609 0.68 CTBP2 (0.43) MAPTALDH1A1RAB9ATSHR
SCHEMBL3344617 0.68 CTBP2 (0.43) MAPTALDH1A1RAB9ATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents WILLIAM MARSH RICE UNIVERSITY (US) 2023-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11767291-B2 Preparation of secondary amines with electrophilic N-linchpin reagents PNMT, NCL, NPM1 KMT2A 127/4885MEN1 296/4885RCE1 1961/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.